Key Financial Data Of Reporting Company

Fuso Pharmaceutical Industries,Ltd. - Filing #7329099

Concept As at
2024-03-31
As at
2024-03-31
As at
2024-03-31
2023-04-01 to
2024-03-31
As at
2024-03-31
As at
2023-03-31
2022-04-01 to
2023-03-31
2021-04-01 to
2022-03-31
As at
2022-03-31
2020-04-01 to
2021-03-31
As at
2021-03-31
As at
2020-03-31
2019-04-01 to
2020-03-31
Key financial data of reporting company
Business results of reporting company
Net sales
55,407,000,000 JPY
51,015,000,000 JPY
49,632,000,000 JPY
49,251,000,000 JPY
46,902,000,000 JPY
Ordinary profit (loss)
1,868,000,000 JPY
2,215,000,000 JPY
1,996,000,000 JPY
2,227,000,000 JPY
1,066,000,000 JPY
Profit (loss)
1,377,000,000 JPY
1,605,000,000 JPY
1,483,000,000 JPY
1,607,000,000 JPY
707,000,000 JPY
Equity in earnings (losses) of affiliates if equity method is applied
JPY
JPY
JPY
JPY
JPY
Share capital
10,758,000,000 JPY
10,758,000,000 JPY
10,758,000,000 JPY
10,758,000,000 JPY
10,758,000,000 JPY
Total number of issued shares
9,451,169 xbrli:shares
9,451,169 xbrli:shares
9,451,169 xbrli:shares
9,451,169 xbrli:shares
9,451,169 xbrli:shares
Net assets
36,661,000,000 JPY
35,649,000,000 JPY
34,532,000,000 JPY
33,683,000,000 JPY
32,302,000,000 JPY
Total assets
75,802,000,000 JPY
72,466,000,000 JPY
69,334,000,000 JPY
69,876,000,000 JPY
69,153,000,000 JPY
Net assets per share
4,290.55
4,064.76
3,936.70
3,839.54
3,681.46
Dividend paid per share
70.00
70.00
60.00
60.00
60.00
Interim dividend paid per share
35.00
30.00
30.00
30.00
30.00
Basic earnings (loss) per share
159.98
183.07
169.09
183.18
80.59
Diluted earnings per share
Equity-to-asset ratio
0.484 xbrli:pure
0.492 xbrli:pure
0.498 xbrli:pure
0.482 xbrli:pure
0.467 xbrli:pure
Rate of return on equity
0.038 xbrli:pure
0.046 xbrli:pure
0.043 xbrli:pure
0.049 xbrli:pure
0.022 xbrli:pure
Price-earnings ratio
13.8 xbrli:pure
10.9 xbrli:pure
12.9 xbrli:pure
13.9 xbrli:pure
26.0 xbrli:pure
Payout ratio
0.438 xbrli:pure
0.382 xbrli:pure
0.355 xbrli:pure
0.328 xbrli:pure
0.744 xbrli:pure
Net cash provided by (used in) operating activities
627,000,000 JPY
2,853,000,000 JPY
3,498,000,000 JPY
3,230,000,000 JPY
5,726,000,000 JPY
Net cash provided by (used in) investing activities
-3,536,000,000 JPY
-1,373,000,000 JPY
-1,553,000,000 JPY
-978,000,000 JPY
-1,485,000,000 JPY
Net cash provided by (used in) financing activities
14,000,000 JPY
-813,000,000 JPY
-1,671,000,000 JPY
-2,446,000,000 JPY
-1,799,000,000 JPY
Cash and cash equivalents
5,120,000,000 JPY
8,014,000,000 JPY
7,347,000,000 JPY
7,074,000,000 JPY
7,268,000,000 JPY
Number of employees
1,307 xbrli:pure
1 xbrli:pure
59 xbrli:pure
1,247 xbrli:pure
1,314 xbrli:pure
1,344 xbrli:pure
1,356 xbrli:pure
1,352 xbrli:pure
Total shareholder return
0.996 xbrli:pure
0.888 xbrli:pure
0.935 xbrli:pure
1.053 xbrli:pure
0.851 xbrli:pure
Total return on share price index
1.962 xbrli:pure
1.388 xbrli:pure
1.312 xbrli:pure
1.286 xbrli:pure
0.905 xbrli:pure

Talk to a Data Expert

Have a question? We'll get back to you promptly.